eIVF® Expands AI Innovation with eVA

Launching with eVA Scribe, the first capability in eIVF’s integrated AI suite

IRVING, Texas--(BUSINESS WIRE)--eIVF®, a portfolio company of Atlantic Street Capital (ASC), continues to advance innovation in reproductive medicine with eVA, an integrated suite of AI-powered capabilities designed to optimize workflows across the practice.

Unlike standalone AI applications that require separate logins, copy and paste workflows, or disconnected systems, eVA is the only AI solution built directly into and fully integrated with eIVF, bringing the power of AI into eIVF’s unified electronic medical records (EMR) solution.

From Conversation to Chart in Seconds

eVA Scribe, the first feature available within the eVA suite, is an AI-assisted documentation tool that transcribes provider and patient conversations in real time, automatically generates visit summaries into a note template, and enables finalized notes to be added directly to the patient chart with a single click.

“eVA is a game changer for physicians who still write their own notes,” said Samuel Chantilis, MD, Medical Director at Dallas - Fort Worth Fertility Associates. “It’s like having a dictation solution built directly into eIVF. eVA saves me time and has a lot of potential to make clinical documentation much easier and more efficient.”

Advancing AI Innovation with eVA

eVA Scribe is just the beginning, with additional cloud-based and AI-powered features planned for release over the upcoming months. “eVA demonstrates our continued success in bringing meaningful AI innovation to fertility practices. As eVA and our cloud strategy continue to mature, we’ll continue to deploy intelligent, fully integrated capabilities that streamline clinic workflows and reduce the administrative burden on providers and staff,” said Nimesh Shah, CEO of eIVF.

eVA reflects eIVF’s commitment to delivering innovation and investing in cloud solutions that help fertility practices improve efficiency, simplify workflows and enhance the overall experience for both providers and their patients.

To schedule a personalized AI workflow demo, please visit eIVF.ai.

About eIVF

eIVF is a leader in healthcare software, serving over 125 fertility practices and clinics worldwide. Since launching in 2002 as one of the first electronic medical record (EMR) platforms designed for Reproductive Endocrinology and Infertility (REI) practices, eIVF has powered more than a million treatment cycles. Committed to driving innovation in fertility care, eIVF continuously evolves to meet the needs of modern clinics with cutting-edge solutions like Fertility Vision, its suite of KPI dashboards that deliver real-time insights to enhance clinical, operational, and financial performance. For more information, visit www.eivf.org.

About Atlantic Street Capital (ASC)

ASC is a private equity firm that invests in lower middle market companies poised for the next level of growth. The firm targets entrepreneurial management partners and fundamentally sound companies between $4 million and $25 million of EBITDA that will benefit from capital investment and ASC’s value-added strategic and operational support. As a result, ASC works closely with management to unlock their business’ underlying value and help them succeed. For more information, visit www.atlanticstreetcapital.com.